Stephen B. Gruber, M.D., Ph.D., M.P.H.
Medical Oncologist
Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma
Biological Therapy/Immunotherapy Chemotherapy Gene Therapy Pain Management Photodynamic Therapy Targeted Therapy
USC Norris Comprehensive Cancer Center Keck Hospital of USC - Medical Center
Dr. Stephen Gruber is a renowned medical oncologist and also the Director of the USC Norris Comprehensive Cancer Center. He is a board certified medical oncologist, epidemiologist, and cancer geneticist that focuses particularly on genetic and environmental improvements to cancer. The main goal of his research is to discover new ways to prevent cancer and to increase treatment and care for cancer patients. Dr. Gruber got his BA Degree from University of Pennsylvania in 1984 and after a while an MA Degree from Yale University in 1986. After he received his Doctorate Degree from Yale University in 1988, Dr. Gruber got accepted at the University of Pennsylvania Medical School and earned his Medical Degree in 1992 where he also finished his internship and residency. Later on, he did two fellowships one in medical oncology, at Johns Hopkins Hospital and one in clinical medical genetics at the University of Michigan. Dr. Gruber earned a series of honors and awards and is the author of over 150 publications. He has been in practice for more than 20 years and is affiliated with the USC Norris Comprehensive Cancer Center and Keck Medical Center of USC. During his career, he has also contributed to many research papers.
American Board of Internal Medicine - Oncology
CA State Medical License 2012 - 2018
Tumor-Infiltrating Lymphocytes, Crohn's-Like Lymphoid Reaction, and Survival From Colorectal Cancer.
Rozek, L. S.,Schmit, S. L.,Greenson, J. K.,Tomsho, L. P.,Rennert, H. S.,Rennert, G.,Gruber, S. B.; J. Natl. Cancer Inst.. 2016 May 14.
See more >>Association of Interferon Regulatory Factor-4 Polymorphism rs12203592 With Divergent Melanoma Pathways.
Gibbs, D. C.,Orlow, I.,Bramson, J. I.,Kanetsky, P. A.,Luo, L.,Kricker, A.,Armstrong, B. K.,Anton-Culver, H.,Gruber, S. B.,Marrett, L. D.,Gallagher, R. P.,Zanetti, R.,R...; J. Natl. Cancer Inst.. 2016 Feb 10.
See more >>Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.
Fehringer, G.,Kraft, P.,Pharoah, P. D.,Eeles, R. A.,Chatterjee, N.,Schumacher, F. R.,Schildkraut, J. M.,Lindstrom, S.,Brennan, P.,Bickeböller, H.,Houlston, R. S.,Landi...; Cancer Res.. 2016 May 20.
See more >>The OncoArray Consortium: a Network for Understanding the Genetic Architecture of Common Cancers.
Cancer Epidemiol Biomarkers Prev. 2016 Oct 3.
See more >>American Society of Clinical Oncology